Prior thiazolidinedione treatment preserves insulin sensitivity in normal rats during acute fatty acid elevation: Role of the liver

Endocrinology

Volumn 143, Issue 12, 2002, Pages 4527-4535

  Ye, Ji Ming ^a,b   Frangioudakis, Georgia ^a   Iglesias, Miguel A ^a   Furler, Stuart M ^a   Ellis, Bronwyn ^a   Dzamko, Nicholas ^a   Cooney, Gregory J ^a   Kraegen, Edward W ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACYL COENZYME A; ADIPONECTIN; HEPARIN DERIVATIVE; INTRALIPID; PIOGLITAZONE; PROTEIN KINASE B; THIAZOLIDINE DERIVATIVE;

ARTICLE; BASAL METABOLIC RATE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FATTY ACID BLOOD LEVEL; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIPID LIVER LEVEL; LIVER FUNCTION; LIVER METABOLISM; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; TRANSPORT KINETICS;

ACYL COENZYME A; ADIPONECTIN; ANIMALS; BLOOD GLUCOSE; FAT EMULSIONS, INTRAVENOUS; FATTY ACIDS, NONESTERIFIED; GLUCOSE; GLUCOSE CLAMP TECHNIQUE; HEPARIN; HYPERINSULINISM; HYPOGLYCEMIC AGENTS; INSULIN; INSULIN RESISTANCE; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; LIVER; MALE; MUSCLE, SKELETAL; PHOSPHORYLATION; PROTEIN-SERINE-THREONINE KINASES; PROTEINS; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-AKT; RATS; RATS, WISTAR; THIAZOLES; THIAZOLIDINEDIONES;

EID: 0036893557     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/en.2002-220387     Document Type: Article

References (40)

1. Spiegelman BM 1998 PPAR-γ: Adipogenic regulator and thiazolidinedione receptor. Diabetes 47:507-514
2. Willson TM, Brown PJ, Sternbach DD, Henke BR 2000 The PPARs: From orphan receptors to drug discovery. J Med Chem 43:527-550
3. Burant CF, Sreenan S, Hirano K, Tai TA, Lohmiller J, Lukens J, Davidson NO, Ross S, Graves RA 1997 Troglitazone action is independent of adipose tissue. J Clin Invest 100:2900-2908
4. Ye JM, Doyle PJ, Iglesias MA, Watson DG, Cooney GJ, Kraegen EW 2001 Peroxisome proliferator-activated receptor (PPAR)-α activation lowers muscle lipids and improves insulin sensitivity in high fat-fed rats: Comparison with PPAR-γ activation. Diabetes 50:411-417
5. Loviscach MRN, Carter L, Mudaliar S, Mohadeen P, Ciaraldi TP, Veerkamp JH, Henry RR 2000 Distribution of peroxisome proliferator-activated receptors (PPARs) in human skeletal muscle and adipose tissue: Relation to insulin resistance. Diabetologia 43:304-311
6. Lapsys NM, Kriketos AD, Lim-Fraser M, Poynten AM, Lowy A, Furler SM, Chisholm DJ, Cooney GJ 2000 Expression of genes involved in lipid metabolism correlate with peroxisome proliferator-activated receptor γ expression in human skeletal muscle. J CIin Endocrinol Metab 85:4293-4297
7. Way JM, Harrington WW, Brown KK, Gottschalk WK, Sundseth SS, Mansfield TA, Ramachandran RK, Willson TM, Kliewer SA 2001 Comprehensive messenger ribonucleic acid profiling reveals that peroxisome proliferator-activated receptor γ activation has coordinate effects on gene expression in multiple insulin-sensitive tissues. Endocrinology 142:1269-1277
8. Brunmair B, Gras F, Neschen S, Roden M, Wagner L, Waldhausl W, Furnsinn C 2001 Direct thiazolidinedione action on isolated rat skeletal muscle fuel handling is independent of peroxisome proliferator-activated receptor-γ-mediated changes in gene expression. Diabetes 50:2309-2315
9. Chao L, Marcus-Samuels B, Mason MM, Moitra J, vinson C, Arioglu E, Gavrilova O, Reitman M L 2000 Adipose tissue is required for the antidiabetic, but not for the hypolipidemic, effect of thiazolidinediones. J Clin Invest 106:1221-1228
10. Boden G, Chen X, Ruiz J, White JV, Rossetti L 1994 Mechanisms of fatty acid-induced inhibition of glucose uptake. J Clin Invest 93:2438-2446
11. Chalkley SM, Hettiarachchi M, Chisholm DJ, Kraegen EW 1998 Five-hour fatty acid elevation increases muscle lipids and impairs glycogen synthesis in the rat. Metabolism 47:1121-1126
12. Griffin ME, Marcucci MJ, Cline GW, Bell K, Barucci N, Lee D, Goodyear LJ, Kraegen EW, White MF, Shulman GI 1999 Free fatty acid-induced insulin resistance is associated with activation of protein kinase Cθ and alterations in the insulin signaling cascade. Diabetes 48:1270-1274
13. Hevener AL, Reichart D, Janez A, Olefsky J 2001 Thiazolidinedione treatment prevents free fatty acid-induced insulin resistance in male Wistar rats. Diabetes 50:2316-2322
14. Radziuk J, Norwich KH, Vranic M 1978 Experimental validation of measurements of glucose turnover in nonsteady state. Am J Physiol 234:E84-E93
15. Rossetti L, Lee YT, Ruiz J, Aldridge SC, Shamoon H, Boden G 1993 Quantitation of glycolysis and skeletal muscle glycogen synthesis in humans. Am J Physiol 265:E761-E769
16. Giaccari A, Rossetti L 1992 Predominant role of gluconeogenesis in the hepatic glycogen repletion of diabetic rats. J Clin Invest 89:36-45
17. Kraegen EW, James DE, Jenkins AB, Chisholm DJ 1985 Dose-response curves for in vivo insulin sensitivity in individual tissues in rats. Am J Physiol 248:E353-E362
18. Stortien LH, James DE, Burleigh KM, Chisholm DJ, Kraegen EW 1986 Fat feeding causes widespread in vivo insulin resistance, decreased energy expenditure, and obesity in rats. Am J Physiol 251:E576-E583
19. Bligh EG, Dyer WJ 1959 A rapid method of total lipid extraction and purification. Can J Biochem Physiol 37:911-917
20. Chan TM, Exton JH 1976 A rapid method for the determination of glycogen content and radioactivity in small quantities. Anal Biochem 71:96-105
21. Antinozzi PA, Segall L, Prentki M, McGarry JD, Newgard CB 1998 Molecular or pharmacologic perturbation of the link between glucose and lipid metabolism is without effect on glucose-stimulated insulin secretion. A re-evaluation of the long-chain acyl-CoA hypothesis. J Biol Chem 273:16146-16154
22. Thompson AL, Lim-Fraser M, Kraegen EW, Cooney GJ 2000 Effects of individual fatty acids on glucose uptake and glycogen synthesis in soleus muscle in vitro. Am J Physiol 279:E577-E584
23. Berg AH, Combs TP, Du X, Brownlee M, Scherer PE 2001 The adipocyte-secreted protein Acrp30 enhances hepatic insulin action. Nat Med 7:947-953
24. Hegarty BD, Cooney GJ, Oakes ND, Kraegen EW, Furter SM 2001 AZ 242, a novel PPAR α/γ agonist, improves insulin sensitivity and increases fatty acid uptake into white adipose tissue of high-fat-fed rats. Diabetes 50:A121-A121
25. Oakes ND; Camilleri S, Furler SM, Chisholm DJ, Kraegen EW 1997 The insulin sensitizer, BRL 49653, reduces systemic fatty acid supply and utilization and tissue lipid availability in the rat. Metabolism 46:935-942
26. Hallakou S, Doare L, Foufelle F, Kergoat M, Guerre-Millo M, Berthault MF, Dugail I, Morin J, Auwerx J, Ferre P 1997 Pioglitazone induces in vivo adipocyte differentiation in the obese Zucker fa/fa rat. Diabetes 46:1393-1399
27. Boden G, Chen X, Rosner J, Barton M 1995 Effects of a 48-h fat infusion on insulin secretion and glucose utilization. Diabetes 44:1239-1242
28. Park JY, Kim CH, Hong SK, Sub KI, Lee KU 1998 Effects of FFA on insulin-stimulated glucose fluxes and muscle glycogen synthase activity in rats. Am J Physiol 275:E338-E344
29. Schmitz-Peiffer C 2000 Signalling aspects of insulin resistance in skeletal muscle: Mechanisms induced by lipid oversupply. Cell Signal 12:583-594
30. Kraegen EW, Cooney GJ, Ye JM, Thompson AL 2001 Triglycerides, fatty acids and insulin resistant-hyperinsulinemia. Exp Clin Endocrinol Diabetes 109:S516-S526
31. Kim YB, Shulman GI, Kahn BB 2002 Fatty acid infusion selectively impairs insulin action on Akt1 and PKCλ/ζ but not on glycogen synthase kinase-3. J Biol Chem 277:32915-32922
32. Song XM, Ryder JW, Kawano Y, Chibalin AV, Krook A, Zierath JR 1999 Muscle fiber type specificity in insulin signal transduction. Am J Physiol 277:R1690-R1696
33. Aoki K, Saito T, Satoh S, Mukasa K, Kaneshiro M, Kawasaki S, Okamura A, Sekihara H 1999 Dehydroepiandrosterone suppresses the elevated hepatic glucose-6-phosphatase and fructose-1, 6-bisphosphatase activities in C57BL/ Ksj-db/db mice: Comparison with troglitazone. Diabetes 48:1579-1585
34. Ahuja HS, Liu S, Crombie DL, Boehm M, Leibowitz MD, Heyman RA, Depre C, Nagy L, Tontonoz P, Davies PJ 2001 Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents. Mol Pharmacol 59:765-773
35. Davies GF, Khandelwal RL, Roesler WJ 1999 Troglitazone induces expression of PPARγ in liver. Mol Cell Biol Res Commun 2:202-208
36. De Vos P, Lefebvre AM, Miller SG, Guerre-Millo M, Wong K, Saladin R, Hamann LG, Staels B, Briggs MR, Auwerx J 1996 Thiazolidinediones repress ob gene expression in rodents via activation of peroxisome proliferator-activated receptor γ. J Clin Invest 98:1004-1009
37. Iwata M, Haruta T, Usui I, Takata Y, Takano A, Uno T, Kawahara J, Ueno E, Sasaoka T, Ishibashi O, Kobayashi M 2001 Pioglitazone ameliorates tumor necrosis factor-α-induced insulin resistance by a mechanism independent of adipogenic activity of peroxisome proliferator-activated receptor-γ. Diabetes 50:1083-1092
38. Maeda N, Takahashi M, Funahashi T, Kihara S, Nishizawa H, Kishida K, Nagaretani H, Matsuda M, Komuro R, Ouchi N, Kuriyama H, Hotta K, Nakamura T, Shimomura I, Matsuzawa Y 2001 PPARγ ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. Diabetes 50:2094-2099
39. Kahn CR, Chen L, Cohen SE 2000 Unraveling the mechanism of action of thiazolidinediones. J Clin Invest 106:1305-1307
40. Combs TP, Berg AH, Obici S, Scherer PE, Rossetti L 2001 Endogenous glucose production is inhibited by the adipose-derived protein Acrp30. J Clin Invest 108:1875-1881